Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2018 | Short report

Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine

Authors: Kjersti Grøtta Vetvik, E. Anne MacGregor, Christofer Lundqvist, Michael Bjørn Russell

Published in: The Journal of Headache and Pain | Issue 1/2018

Abstract

Background

Menstrual migraine (MM) and premenstrual syndrome (PMS) are two conditions linked to specific phases of the menstrual cycle. The exact pathophysiological mechanisms are not fully understood, but both conditions are hypothesized to be triggered by female sex hormones. Co-occurrence of MM and PMS is controversial. The objective of this population-based study was to compare self-assessed symptoms of PMS in female migraineurs with and without MM. A total of 237 women from the general population who self-reported migraine in at least50% of their menstruations in a screening questionnaire were invited to a clinical interview and diagnosed by a neurologist according to the International Classification of Headache Disorders II (ICHD II), including the appendix criteria for MM. All women were asked to complete a self-administered form containing 11 questions about PMS-symptoms adapted from the Diagnostic and Statistical Manual of Mental Disorders. The number of PMS symptoms was compared among migraineurs with and without MM. In addition, each participant completed the Headache Impact test (HIT-6) and Migraine Disability Assessment Score (MIDAS).

Findings

A total of 193 women returned a complete PMS questionnaire, of which 67 women were excluded from the analyses due to current use of hormonal contraception (n = 61) or because they did not fulfil the ICHD-criteria for migraine (n = 6). Among the remaining 126 migraineurs, 78 had MM and 48 non-menstrually related migraine. PMS symptoms were equally frequent in migraineurs with and without MM (5.4 vs. 5.9, p = 0.84). Women with MM reported more migraine days/month, longer lasting migraine attacks and higher HIT-6 scores than those without MM, but MIDAS scores were similar.

Conclusion

We did not find any difference in number of self-reported PMS-symptoms between migraineurs with and without MM.

Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16(1):76–87. https://doi.org/10.1016/s1474-4422(16)30293-9 CrossRefPubMed

Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J (1995) Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 24(3):612–618CrossRef

MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67(12):2154–2158. https://doi.org/10.1212/01.wnl.0000233888.18228.19 CrossRefPubMed

Headache Classification Subcommittee of the International Headache Society (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211

Headache Classification Subcommittee of the International Headache Society (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629–808. https://doi.org/10.1177/0333102413485658 CrossRef

Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160

Vetvik KG, Macgregor EA, Lundqvist C, Russell MB (2014) Prevalence of menstrual migraine: a population-based study. Cephalalgia 34(4):280–288. https://doi.org/10.1177/0333102413507637 CrossRefPubMed

Tepper SJ, Zatochill M, Szeto M, Sheftell F, Tepper DE, Bigal M (2008) Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool. Headache 48(10):1419–1425. https://doi.org/10.1111/j.1526-4610.2008.01304. CrossRefPubMed

O'Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman E, Halbreich U, Ismail KM, Panay N, Pearlstein T, Rapkin A, Reid R, Schmidt P, Steiner M, Studd J, Yonkers K (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 14(1):13–21. https://doi.org/10.1007/s00737-010-0201-3 CrossRefPubMedPubMedCentral

10.

American Psychiatric Association (2013) DIagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Press, Washington DCCrossRef

11.

Ismaili E, Walsh S, O'Brien PM, Backstrom T, Brown C, Dennerstein L, Eriksson E, Freeman EW, Ismail KM, Panay N, Pearlstein T, Rapkin A, Steiner M, Studd J, Sundstrom-Paromma I, Endicott J, Epperson CN, Halbreich U, Reid R, Rubinow D, Schmidt P, Yonkers K (2016) Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health 19(6):953–958. https://doi.org/10.1007/s00737-016-0631-7 CrossRefPubMed

12.

Sadler C, Smith H, Hammond J, Bayly R, Borland S, Panay N, Crook D, Inskip H (2010) Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women's survey. J Women's Health (Larchmt) 19(3):391–396. https://doi.org/10.1089/jwh.2008.1210 CrossRef

13.

Halbreich U (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28(Suppl 3):55–99CrossRef

14.

Mattsson P (2003) Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 43(1):27–35CrossRef

15.

Facchinetti F, Neri I, Martignoni E, Fioroni L, Nappi G, Genazzani AR (1993) The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 13(6):422–425CrossRef

16.

Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH (2003) Migraine prevalence during menopausal transition. Headache 43(5):470–478CrossRef

17.

Yamada K (2016) High prevalence of menstrual migraine comorbidity in patients with premenstrual dysphoric disorder: retrospective survey. Cephalalgia 36(3):294–295. https://doi.org/10.1177/0333102415586066 CrossRefPubMed

18.

Facchinetti F (1994) The premenstrual syndrome belongs in the diagnostic criteria for menstrual migraine. Cephalalgia 14(6):413–414CrossRef

19.

Gupta VK (1994) Menstrual migraine is not pathogenetically related to premenstrual syndrome. Cephalalgia 14(6):411–412CrossRef

20.

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders -DSM IV. American Psychiatric Association, Washington DC

21.

WHO (1996) International classification og diseases, 10th revision. WHO, Geneva

22.

Management of Premenstrual Syndrome: Green-top Guideline No. 48 (2017). BJOG : an international journal of obstetrics and gynaecology 124 (3):e73-e105. doi:https://doi.org/10.1111/1471-0528.14260

23.

Vetvik KG, MacGregor EA, Lundqvist C, Russell MB (2015) A clinical interview versus prospective headache diaries in the diagnosis of menstrual migraine without aura. Cephalalgia 35(5):410–416. https://doi.org/10.1177/0333102414545891 CrossRefPubMed

24.

Fragoso YD, Guidoni AC, de Castro LB (2009) Characterization of headaches in the premenstrual tension syndrome. Arq Neuropsiquiatr 67(1):40–42CrossRef

25.

Laurell K, Artto V, Bendtsen L, Hagen K, Haggstrom J, Linde M, Soderstrom L, Tronvik E, Wessman M, Zwart JA, Kallela M (2015) Premonitory symptoms in migraine: a cross-sectional study in 2714 persons. Cephalalgia. https://doi.org/10.1177/0333102415620251 CrossRef

26.

Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553–622. https://doi.org/10.1152/physrev.00034.2015 CrossRefPubMedPubMedCentral

27.

Akerman S, Goadsby PJ (2007) Dopamine and migraine: biology and clinical implications. Cephalalgia 27(11):1308–1314. https://doi.org/10.1111/j.1468-2982.2007.01478. CrossRefPubMed

28.

Pavlovic JM, Allshouse AA, Santoro NF, Crawford SL, Thurston RC, Neal-Perry GS, Lipton RB, Derby CA (2016) Sex hormones in women with and without migraine: evidence of migraine-specific hormone profiles. Neurology 87(1):49–56. https://doi.org/10.1212/wnl.0000000000002798 CrossRefPubMedPubMedCentral

29.

Yonkers KA, O'Brien PM, Eriksson E (2008) Premenstrual syndrome. Lancet 371(9619):1200–1210. https://doi.org/10.1016/s0140-6736(08)60527-9 CrossRefPubMedPubMedCentral

30.

Halbreich U, Alt IH, Paul L (1988) Premenstrual changes. Impaired hormonal homeostasis. Endocrinol Metabol Clin North Am 17(1):173–194CrossRef

31.

Halbreich U, Endicott J, Goldstein S, Nee J (1986) Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74(6):576–586CrossRef

32.

Lichten EM, Lichten JB, Whitty A, Pieper D (1996) The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test. Headache 36(6):367–371CrossRef

33.

MacGregor EA (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3(6):354–361. https://doi.org/10.1016/s1474-4422(04)00768-9 CrossRefPubMed

Title: Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine
Authors: Kjersti Grøtta Vetvik
E. Anne MacGregor
Christofer Lundqvist
Michael Bjørn Russell
Publication date: 01-12-2018
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-018-0931-6

At a glance: The STEP trials

Springer Medicine

Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine

Abstract

Background

Findings

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Findings

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

European Headache Federation guideline on idiopathic intracranial hypertension

Increased thalamic glutamate/glutamine levels in migraineurs

PACAP38 and PAC1 receptor blockade: a new target for headache?

Evidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients: a study comparing 18FDG-PET and visual evoked potentials

Migraine is first cause of disability in under 50s: will health politicians now take notice?

Effectiveness of transcutaneous electrical nerve stimulation for the treatment of migraine: a meta-analysis of randomized controlled trials